Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

American Journal of Medicine

Volumn 122, Issue 3, 2009, Pages 290-300

  Wald, David S ^a   Law, Malcolm ^a   Morris, Joan K ^a   Bestwick, Jonathan P ^a   Wald, Nicholas J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Angiotensin converting enzyme inhibitor; Beta blocker; Blood pressure; Calcium channel blocker; Combination blood pressure therapy; Randomized trial; Thiazide

Indexed keywords

AMLODIPINE; ATENOLOL; BENAZEPRIL; BISOPROLOL; CAPTOPRIL; CHLORTALIDONE; CILAZAPRIL; DILTIAZEM; ENALAPRIL; FELODIPINE; FOSINOPRIL; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LACIDIPINE; LISINOPRIL; NEBIVOLOL; NIFEDIPINE; NITRENDIPINE; PERINDOPRIL; PINDOLOL; PROPRANOLOL; QUINAPRIL; RAMIPRIL; TIMOLOL; TRANDOLAPRIL; VERAPAMIL;

ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COMPARATIVE STUDY; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; META ANALYSIS; MONOTHERAPY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THIAZIDES;

EID: 61649091385     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.09.038     Document Type: Article

References (63)

1. Williams B., Poulter N.R., Brown M.J., et al. Guidelines for the management of hypertension: report of the fourth working party of the British Hypertension Society, 2004 - BHSIV. J Hum Hypertens 18 (2004) 139-185
2. CG18 Hypertension (persistently high blood pressure) in adults-NICE guideline. Available at: www.nice.org.uk.
3. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 289 (2003) 2560-2573
4. The Taskforce for the management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Guidelines for the Management of Arterial Hypertension. J Hypertens 25 (2007) 1105-1187
5. Law M.R., Wald N.J., Morris J.K., and Jordan R.E. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 326 (2003) 1427-1434
6. Frishman W.H., Bryzinski B.S., Coulson L.R., et al. A multifactorial trial design to assess combination therapy in hypertension. Arch Intern Med 154 (1994) 1461-1468
7. Moser M., and Prisant L.M. Low-dose combination therapy in hypertension. Am Fam Physician 56 (1997) 1275-1279
8. Rosenthal T., and Gavras I. Fixed-dose combinations as first-line treatment for hypertension. Prog Cardiovasc Dis 48 (2006) 416-425
9. Fretheim A., and Oxman A.D. International variation in prescribing antihypertensive drugs: its extent and possible explanations. BMC Health Serv Res 5 (2005) 21
10. Bateman D.N., Dean C.R., Mucklow J.C., et al. Atenolol and chlorthalidone in combination for hypertension. Br J Clin Pharmacol 7 (1979) 357-363
11. Chalmers J.P., Korner P.I., Tiller D.J., et al. Double-blind factorial trial of prindolol and hydrochlorothiazide in hypertension. Med J Aust 1 (1976) 650-653
12. Chalmers J., Horvath J., Tiller D., and Bune A. Effects of timolol and hydrochlorothiazide on blood-pressure and plasma renin activity. Lancet 2 (1976) 328-331
13. Chalmers J.P., Wing L.M.H., Grygiel J.J., et al. Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting. Eur J Clin Pharmacol 22 (1982) 191-196
14. Chrysant S.G., Chappel C., Farnham J., et al. Antihypertensive and metabolic effects of single and combined atenolol regimens. J Clin Pharmacol 32 (1992) 61-65
15. Durel L.A., Hayashi P.J., Weidler D.J., and Schneiderman N. Effectiveness of antihypertensive medications in office and ambulatory settings: a placebo-controlled comparison of atenolol, metoprolol, chlorthalidone, verapamil, and an atenolol-chlorthalidone combination. J Clin Pharmacol 32 (1992) 564-570
16. Erwteman T.M., Nagelkerke N., Lubsen J., et al. b Blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial. BMJ 289 (1984) 406-409
17. Frishman W.H., Burris J.F., Mroczek W.J., et al. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol 35 (1995) 182-188
18. Lacourcière Y., and Arnott W. Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients. J Hum Hypertens 8 (1994) 283-288
19. Zachariah P.K., Messerli F.H., and Mroczek W. Low-dose bisoprolol/hydrochlorothiazide: an option in first-line, antihypertensive treatment. Clin Ther 15 (1993) 779-787
20. Brown C.L., Backhouse C.I., Grippat J.C., and Santoni J.P. The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects. Eur J Clin Pharmacol 39 (1990) 327-332
21. Canter D., Frank G.J., Knapp L.E., et al. Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. J Hum Hypertens 8 (1994) 155-162
22. Chalmers J.P., Morris M.J., Wing L.M.H., et al. Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system, and atrial natriuretic factor in essential hypertension: a double blind factorial cross-over study. Aust NZ J Med 16 (1986) 475-480
23. Chrysant S.G. Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. Arch Intern Med 154 (1994) 737-743
24. Chrysant S.G., Fagan T., Glazer R., and Kriegman A. Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension. Arch Fam Med 5 (1996) 17-24
25. Fernández M., Madero R., González D., et al. Combined versus single effect of fosinopril and hydrochlorothiazide in hypertensive patients. Hypertension 23 Suppl I (1994) I-207-I-210
26. Kayanakis J.G., and Baulac L. Comparative study of once-daily administration of captopril 50 mg, hydrochlorothiazide 25 mg and their combination in mild to moderate hypertension. Br J Clin Pharmacol 23 Suppl 1 (1987) 89S-92S
27. Pool J., Cushman W.C., Saini R.K., et al. Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension. Am J Hypertens 10 (1997) 117-123
28. Pordy R.C. Cilazapril plus hydrochlorothiazide: improved efficacy without reduced safety in mild to moderate hypertension. Cardiology 85 (1994) 311-322
29. Scholze J., Breitstadt A., Cairns V., et al. Ramipril and hydrochlorothiazide combination therapy in hypertension: a clinical trial of factorial design. J Hypertens 11 (1993) 217-221
30. Burris J.F., Weir M.R., Oparil S., et al. An assessment of diltiazem and hydrochlorothiazide in hypertension. JAMA 263 (1990) 1507-1512
31. Pool P.E., Applegate W.B., Woehler T., et al. A randomized, controlled trial comparing diltiazem, hydrochlorothiazide, and their combination in the therapy of essential hypertension. Pharmacotherapy 13 (1993) 487-493
32. Salvetti A., Magagna A., Innocenti P., et al. The combination of chlorthalidone with nifedipine does not exert an additive antihypertensive effect in essential hypertensives: a crossover multicenter study. J Cardiovasc Pharmacol 17 (1991) 332-335
33. Weir M.R., Weber M.A., Punzi H.A., et al. A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension. J Hum Hypertens 6 (1992) 133-138
34. Wing L.M.H., Arnolda L.F., Harvey P.J., et al. Lacidipine, hydrochlorothiazide and their combination in systolic hypertension in the elderly. J Hypertens 15 (1997) 1503-1510
35. Wald D.S., Law M., Mills S., et al. A 16-week, randomized, double-blind placebo-controlled cross-over trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a β-blocker on blood pressure reduction. Clin Ther 30 (2008) 2030-2039
36. Wing L.M.H., Chalmers J.P., West M.J., et al. Enalapril and atenolol in essential hypertension: attenuation of hypertensive effects in combination. Clin Exp Hypertens 10 (1988) 119-133
37. Clement D.L., De Pue N.Y., and Packet L. Effect of calcium antagonists on ambulatory blood pressure and its variations. J Cardiovasc Pharmacol 10 Suppl 10 (1987) S117-S119
38. Dargie H., Cleland J., Findlay I., et al. Combination of verapamil and beta-blockers in systemic hypertension. Am J Cardiol 57 (1986) 80D-82D
39. Lyons D., Fowler G., Webster J., et al. An assessment of lacidipine and atenolol in mild to moderate hypertension. Br J Clin Pharmacol 37 (1994) 45-51
40. Maclean D., Mitchell E.T., Lewis R., et al. Comparison of once daily atenolol, nitrendipine and their combination in mild to moderate essential hypertension. Br J Clin Pharmacol 29 (1990) 455-463
41. McInnes G.T., Findlay I.N., Murray G., et al. Cardiovascular responses to verapamil and propranolol in hypertensive patients. J Hypertens 3 Suppl 3 (1985) 219-221
42. Tonkin A.L., Wing L.M.H., Russell A.E., et al. Diltiazem and atenolol in essential hypertension: additivity of effects on blood pressure and cardiac conduction with combination therapy. J Hypertens 8 (1990) 1015-1018
43. Chan P., Lin C., Tomlinson B., et al. Additive effects of diltiazem and lisinopril in treatment of elderly patients with mild-to-moderate hypertension. Am J Hypertens 10 (1997) 743-749
44. Cushman W.C., Cohen J.D., Jones R.P., et al. Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension. Am J Hypertens 11 (1998) 23-30
45. Frishman W.H., Ram C.V.S., McMahon F.G., et al. Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: a randomized, double-blind, placebo-controlled, parallel-group study. J Clin Pharmacol 35 (1995) 1060-1066
46. Kuschnir E., Acuña E., Sevilla D., et al. Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 10 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo. Clin Ther 18 (1996) 1213-1224
47. Levine J.H., Ferdinand K.C., Cargo P., et al. Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension. Am J Hypertens 8 (1995) 494-499
48. Messerli F., Frishman W.H., and Elliott W.J. Effects of verapamil and trandolapril in the treatment of hypertension. Am J Hypertens 11 (1998) 322-327
49. Scholze J., Zilles P., and Compagnone D. Verapamil SR and trandolapril combination therapy in hypertension-a clinical trial of factorial design. Br J Clin Pharmacol 45 (1998) 491-495
50. Scholze J., Bauer B., and Massaro J. Antihypertensive profiles with ascending dose combinations of ramipril and felodipine ER. Clin Exp Hypertens 21 (1999) 1447-1462
51. Veratran Study Group. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure. Am J Hypertens 10 (1997) 492-499
52. Law M., Wald N., and Morris J. Lowering blood pressure to prevent myocardial infarction and strokes: a new preventive strategy. Health Technol Assess 7 (2003) 31
53. Kochar M., Guthrie R., Triscari J., et al. Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension. Am J Hypertens 12 (1999) 797-805
54. Benz J.R., Black H.R., Graff A., et al. Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy. J Hum Hypertens 12 (1998) 861-866
55. Mackay J.H., Arcuri K.E., Goldberg A.I., et al. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. Arch Intern Med 156 (1996) 278-285
56. Chrysant S.G., Melino M., Karki S., et al. The Combination of Olmesartan Medoxomil and Amlodipine Besylate in Controlling High Blood Pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. Clin Ther 30 (2008) 587-604
57. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data from one million adults in 61 prospective studies. Lancet 360 (2002) 1903-1913
58. Law M., Morris J.K., and Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease. BMJ (2009) In press
59. Hansson L., Zanchetti A., Carruthers S.G., et al., HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351 (1998) 1755-1762
60. Lui L., Zhang Y., Liu G., et al., FEVER Study Group. The felodipine event reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens 23 (2005) 2157-2172
61. Neaton J.D., Grimm R.H., Prineas R.J., et al., Treatment of Mild Hypertension Study Research Group (TOMHS). Treatment of Mild Hypertension Study. JAMA 270 (1998) 713-724
62. Schrier R.W., Estacio R.O., Esler A., and Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes (the second Appropriate Blood Pressure Control in Diabetes (ABCD) trial). Kidney Int 61 (2002) 1086-1097
63. Asselbergs F.W., Diercks G.F.H., Hillege H.L., et al., Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVENDIT) Investigators. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 110 (2004) 2809-2816